The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Investigation of probiotics in multiple sclerosis
Open accessAbstract
None of the disease-modifying therapies (DMTs) currently being used for the management of multiple sclerosis (MS) are 100% effective. In addition, side effects associated with the use of these DMTs have limited the practice of combination therapy. Hence, there is a need for safe immunomodulatory agents to fine-tune the management of MS. The gut microbiome plays an important role in autoimmunity, and several studies have reported alterations in the gut microbiome of MS patients. Studies in animal model of MS have identified members of the gut commensal microflora that exacerbate or ameliorate neuroinflammation. Probiotics represent an oral, non-toxic immunomodulatory agent that could be used in combination with current MS therapy. We designed a pilot study to investigate the effect of VSL3 on the gut microbiome and peripheral immune system function in healthy controls and MS patients. VSL3 administration was associated with increased abundance of many taxa with enriched taxa predominated by Lactobacillus, Streptococcus, and Bifidobacterium species. At the immune level, VSL3 administration induced an anti-inflammatory peripheral immune response characterized by decreased frequency of intermediate monocytes (CD14 high CD16 low ), decreased mean fluorescence intensity (MFI) of CD80 on classical monocytes as well as decreased human leukocyte antigen–antigen D related (HLA-DR) MFI on dendritic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, probiotics supplementations have a therapeutic potential to ameliorate MS, improving the disability status, the mental health, and some inflammatory and metabolic parameters, compared to the placebo group (148, 149).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [149]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data
Kopylova, E., Noé, L., & Touzet, H. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts611 · Cited by 3,051
Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., Wu, X., Li, J., Tang, L., Li, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3914 · Cited by 1,690
Rothhammer, V., Mascanfroni, I. D., Bunse, L., Takenaka, M. C., Kenison, J. E., Mayo, L., Chao, C.-C., Patel, B., Yan, R., Blain, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4106 · Cited by 1,559
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323
Alterations of the human gut microbiome in multiple sclerosis
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307
Self-citationCommensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial
Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K. M., Brigidi, P., Vitali, B., Poggioli, G., Miglioli, M., & Campieri, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00171-9 · Cited by 1,147
Research works printed but not linked: 1
- Anderson MJ, 2001, Austral Ecology, 26, 32
Cited by
Sorted by citations
The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology
Rutsch, A., Kantsjö, J. B., & Ronchi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604179 · Cited by 821
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1434-3 · Cited by 767
The impact of the gut microbiome on extra-intestinal autoimmune diseases
Miyauchi, E., Shimokawa, C., Steimle, A., Desai, M. S., & Ohno, H. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00727-y · Cited by 384
Microglia, Lifestyle Stress, and Neurodegeneration
Madore, C., Yin, Z., Leibowitz, J. A., & Butovsky, O. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.003 · Cited by 313
Impacts of microbiome metabolites on immune regulation and autoimmunity
Haase, S., Haghikia, A., Wilck, N., Müller, D. N., & Linker, R. A. (2018) · Immunology · doi:10.1111/imm.12933 · Cited by 239
The microbiota-immune axis as a central mediator of gut-brain communication
Fung, T. C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104714 · Cited by 234
The role of the microbiota-gut-brain axis in neuropsychiatric disorders
Generoso, J. S., Giridharan, V. V., Lee, J., Macêdo, D. S., & Barichello, T. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0987 · Cited by 250
Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204
Lactobacillus reuteri tryptophan metabolism promotes host susceptibility to CNS autoimmunity
Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Microbiome · doi:10.1186/s40168-022-01408-7 · Cited by 208
The Impact of Gut Microbiota on Radiation-Induced Enteritis
Jian, Y., Zhang, D., Liu, M., Wang, Y., & Xu, Z. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.586392 · Cited by 170
Short-chain fatty acids-producing probiotics: A novel source of psychobiotics
Cheng, Y., Liu, J., & Ling, Z. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1920884 · Cited by 156
Sodium in the microenvironment regulates immune responses and tissue homeostasis
Müller, D. N., Wilck, N., Haase, S., Kleinewietfeld, M., & Linker, R. A. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-018-0113-4 · Cited by 149
Hesperidin Effects on Gut Microbiota and Gut-Associated Lymphoid Tissue in Healthy Rats
Estruel‐Amades, S., Massot‐Cladera, M., Pérez-Cano, F. J., Franch, À., Castell, M., & Camps‐Bossacoma, M. (2019) · Nutrients · doi:10.3390/nu11020324 · Cited by 134
Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review
Ordoñez-Rodriguez, A., Román, P., Rueda‐Ruzafa, L., Campos-Ríos, A., & Cardona, D. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20054624 · Cited by 144
Spichak, S., Bastiaanssen, T. F. S., Berding, K., Vlckova, K., Clarke, G., Dinan, T. G., & Cryan, J. F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.044 · Cited by 127
Morshedi, M., Hashemi, R., Moazzen, S., Sahebkar, A., & Hosseinifard, E.-S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1611-4 · Cited by 125
Zhang, W., Zhu, B., Xu, J., Liu, Y., Qiu, E., Li, Z., Li, Z., He, Y., Zhou, H., Bai, Y., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01040 · Cited by 123
Buhaș, M. C., Gavrilaș, L. I., CANDREA, A. R., Cătinean, A., Mocan, A., Miere, D., & Tataru, A. D. (2022) · Nutrients · doi:10.3390/nu14142970 · Cited by 134
Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity
Montgomery, T. L., Künstner, A., Kennedy, J. J., Fang, Q., Asarian, L., Culp‐Hill, R., D’Alessandro, A., Teuscher, C., Busch, H. S., & Krementsov, D. N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002817117 · Cited by 121
Probiotics: If It Does Not Help It Does Not Do Any Harm. Really?
Lerner, A., Shoenfeld, Y., & Matthias, T. (2019) · Microorganisms · doi:10.3390/microorganisms7040104 · Cited by 117
Targeting the gut to treat multiple sclerosis
Ghezzi, L., Cantoni, C., Pinget, G. V., Zhou, Y., & Piccio, L. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143774 · Cited by 116
The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
Kirby, T. O., & Ochoa‐Repáraz, J. (2018) · Medical Sciences · doi:10.3390/medsci6030069 · Cited by 114
Parodi, B., & de Rosbo, N. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718220 · Cited by 114
Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders
Shahbazi, R., Yasavoli‐Sharahi, H., Alsadi, N., Ismail, N., & Matar, C. (2020) · Molecules · doi:10.3390/molecules25214891 · Cited by 102
Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis
Li, K., Wei, S., Hu, L., Yin, X., Mai, Y., Jiang, C., Peng, X., Cao, X., Huang, Z., Zhou, H., et al. (2020) · Mediators of Inflammation · doi:10.1155/2020/2058272 · Cited by 92
High animal protein diet and gut microbiota in human health
Cai, J., Chen, Z., Wu, W., Lin, Q., & Liang, Y. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1898336 · Cited by 102
Salami, M., Kouchaki, E., Asemi, Z., & Tamtaji, O. R. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.10.023 · Cited by 93
Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms
Murdaca, G., Greco, M., Borro, M., & Gangemi, S. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102845 · Cited by 91
Limosilactobacillus reuteri in immunomodulation: molecular mechanisms and potential applications
Luo, Z., Chen, A., Xie, A., Liu, X., Jiang, S., & Yu, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1228754 · Cited by 86
Tilocca, B., Pieroni, L., Soggiù, A., Britti, D., Bonizzi, L., Roncada, P., & Greco, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114045 · Cited by 86
Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases
Yuan, C., He, Y., Xie, K., Feng, L., Gao, S., & Cai, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1282431 · Cited by 87
Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome
Camara-Lemarroy, C. R., Metz, L. M., & Yong, V. W. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i37.4217 · Cited by 77
Zeng, L., Yang, K., He, Q., Zhu, X., Long, Z., Wu, Y., Chen, J., Li, Y., Zeng, J., Cui, G., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03303-4 · Cited by 72
Asghari, K. M., Dolatkhah, N., Ayromlou, H., Mirnasiri, F., Dadfar, T., & Hashemian, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-46047-6 · Cited by 67
The role of the gut microbiota and microbial metabolites in neuroinflammation
Haase, S., Wilck, N., Haghikia, A., Gold, R., Mueller, D. N., & Linker, R. A. (2020) · European Journal of Immunology · doi:10.1002/eji.201847807 · Cited by 65
Dargahi, N., Matsoukas, J., & Apostolopoulos, V. (2020) · Brain Sciences · doi:10.3390/brainsci10020126 · Cited by 60
Probiotics and the Treatment of Parkinson's Disease: An Update
Mirzaei, H., Sedighi, S., Kouchaki, E., Barati, E., Dadgostar, E., Aschner, M., & Tamtaji, O. R. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01128-w · Cited by 57
Jiang, J., Chu, C., Wu, C., Wang, C., Zhang, C., Li, T., Zhai, Q., Yu, L., Tian, F., & Chen, W. (2021) · Food & Function · doi:10.1039/d0fo03203d · Cited by 52
Gut microbiota: a new insight into neurological diseases
Liu, L., Wang, H., Chen, X., & Xie, P. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002212 · Cited by 52
Ertürk-Hasdemir, D., Ochoa‐Repáraz, J., Kasper, D. L., & Kasper, L. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.662807 · Cited by 51
Calvo‐Barreiro, L., Eixarch, H., Alonso, M. P., Castillo, M., Lebrón‐Galán, R., Mestre, L., Guaza, C., Clemente, D., del Campo, R., Montalbán, X., et al. (2020) · Cells · doi:10.3390/cells9040906 · Cited by 48
The Role of Gut Microbiome in the Pathogenesis of Multiple Sclerosis and Related Disorders
Dunalska, A., Saramak, K., & Szejko, N. (2023) · Cells · doi:10.3390/cells12131760 · Cited by 45
Hashemi, B., Abdollahi, M., Abbaspour‐Aghdam, S., Hazrati, A., Malekpour, K., Meshgi, S., Kafil, H. S., Ghazi, F., Yousefi, M., Roshangar, L., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114195 · Cited by 49
Blais, L. L., Montgomery, T. L., Amiel, E., Deming, P. B., & Krementsov, D. N. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1943289 · Cited by 45
Modification of the gut microbiome to combat neurodegeneration
Sasmita, A. O. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0005 · Cited by 50
Mestre, L., Carrillo-Salinas, F. J., Mecha, M., Feliú, A., & Guaza, C. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.037 · Cited by 43
The Evolving Landscape of Fecal Microbial Transplantation
Shao, T., Hsu, R., Hacein-Bey, C., Zhang, W., Gao, L., Kurth, M. J., Zhao, H., Shuai, Z., & Leung, P. S. C. (2023) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-023-08958-0 · Cited by 43
Role of diet in regulating the gut microbiota and multiple sclerosis
Sanchez, J. M. S., DePaula-Silva, A. B., Libbey, J. E., & Fujinami, R. S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108379 · Cited by 42
Yassin, L. K., Skrabulyte-Barbulescu, J., Alshamsi, S. H., Saeed, S., Alkuwaiti, S. H., Almazrouei, S., Alnuaimi, A., BaniYas, S., Aldhaheri, D., Alderei, M., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1667448 · Cited by 48
Ghassab, F. T., Mahmoudi, F. S., Tinjani, R. T., Meibodi, A. E., Zali, M. R., & Yadegar, A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122748 · Cited by 40
Hosseini, S. A., Nematollahi, S., Husain, D., Banaei-Jahromi, N., Majdinasab, N., & Hosseini, S. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.901846 · Cited by 40
Multiple Sclerosis and Microbiome
Preiningerova, J. L., Zakostelska, Z. J., Srinivasan, A., Tichá, V., Kovářová, I., Kleinová, P., Tlaskalová-Hogenová, H., & Havrdová, E. (2022) · Biomolecules · doi:10.3390/biom12030433 · Cited by 43
Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases
Marietta, E. V., Mangalam, A. K., Taneja, V., & Murray, J. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573079 · Cited by 36
Askari, G., Ghavami, A., Shahdadian, F., & Moravejolahkami, A. R. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.015 · Cited by 36
Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis
Atabati, H., Yazdanpanah, E., Mortazavi, H., Bajestani, S. G., Raoofi, A., Esmaeili, S., Khaledi, A., Saburi, E., Afshari, J. T., Sathyapalan, T., et al. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_6 · Cited by 38
Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review
Mincic, A. M., Antal, M., Filip, L. A., & Miere, D. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.05.036 · Cited by 41
O’Callaghan, A. A., & Corr, S. C. (2019) · Microorganisms · doi:10.3390/microorganisms7120663 · Cited by 35
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health
Bhatia, N. Y., Jalgaonkar, M. P., Hargude, A. B., Sherje, A. P., Oza, M. J., & Doshi, G. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220822172039 · Cited by 38
Montgomery, T. L., Peipert, D., & Krementsov, D. N. (2024) · Immunological Reviews · doi:10.1111/imr.13343 · Cited by 38
Chui, Z. S. W., Chan, L. M. L., Zhang, E. W. H., Liang, S., Choi, E. P. H., Lok, K. Y. W., Tun, H. M., & Kwok, J. Y. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-59250-w · Cited by 45
Mirashrafi, S., Taghanaki, S. Z. H., Sarlak, F., Moravejolahkami, A. R., Kermani, M. A. H., & Haratian, M. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14724 · Cited by 31
Dziedzic, A., & Saluk, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214478 · Cited by 31
Diet-microbiome-gut-brain nexus in acute and chronic brain injury
Krakovski, M., Arora, N., Jain, S., Glover, J., Dombrowski, K. E., Hernandez, B., Yadav, H., & Sarma, A. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1002266 · Cited by 27
The role of multiple sclerosis therapies on the dynamic of human gut microbiota
Văcăraș, V., Muresanu, D. F., Buzoianu, A. D., Nistor, C., Vesa, Ș. C., Paraschiv, A.-C., Botos-Vacaras, D., Văcăraș, C., & Vithoulkas, G. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578087 · Cited by 28
The gut microbiota perspective for interventions in MS
Żołędziewska, M. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.03.016 · Cited by 25
Ullah, H., Товчига, О. В., Daglia, M., & Khan, H. Z. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210217084827 · Cited by 25
Petersen, M. J., Bergien, S. O., & Stærk, D. (2021) · Phytotherapy Research · doi:10.1002/ptr.7050 · Cited by 25
Zißler, J., Rothhammer, V., & Linnerbauer, M. (2024) · Cells · doi:10.3390/cells13060497 · Cited by 24
Bugbee, E., Wang, A. A., & Gommerman, J. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188750 · Cited by 23
Gut flora in multiple sclerosis: implications for pathogenesis and treatment
Zhang, W., Wang, Y., Zhu, M., Liu, K., & Zhang, H. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.387974 · Cited by 24
Tsogka, A., Kitsos, D. K., Stavrogianni, K., Giannopapas, V., Chasiotis, A. K., Christouli, N., Tsivgoulis, G. K., Tzartos, J. S., & Giannopoulos, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247610 · Cited by 21
Träger, C., Kaiser, M., Freudenstein, D., Heckscher, S., Dettmer, K., Oefner, P. J., Liebisch, G., Hiergeist, A., Gessner, A., Lee, D.-H., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105743 · Cited by 21
Kim, J. H., Choi, Y., Lee, S.-M., & Oh, M. S. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2024.215 · Cited by 22
Dell’Atti, F., Abreu, H., Malfa, P., Raineri, D., Cappellano, G., & Chiocchetti, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1620185 · Cited by 24
Zhang, M., Li, W., Wang, X., Wu, Y., Chen, X., Zhang, H., Yang, L.-Q., Wu, C.-Z., Zhang, S., Chen, Y., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1095053 · Cited by 19
Ramalho, J. B., Spiazzi, C. C., Bicca, D. F., Rodrigues, J. F., Sehn, C. P., da Silva, W. P., & Cibin, F. W. S. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113847 · Cited by 19
Essmat, N., Karádi, D. Á., Zádor, F., Király, K. P., Fürst, S., & Al‐Khrasani, M. (2023) · Molecules · doi:10.3390/molecules28237766 · Cited by 18
Microbiota, IgA and Multiple Sclerosis
Boussamet, L., Rajoka, M. S. R., & Berthelot, L. (2022) · Microorganisms · doi:10.3390/microorganisms10030617 · Cited by 20
Wickstead, E. S., Elliott, B., Pokorny, S., Biggs, C. S., Getting, S. J., & McArthur, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115996 · Cited by 20
Development and management of gastrointestinal symptoms in long-term COVID-19
He, K.-Y., Lei, X., Zhang, L., Wu, D., Li, J., Lu, L., Laila, U. E., Cui, C.-Y., Xu, Z.-X., & Jian, Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1278479 · Cited by 17
Guo, X., Wang, J., Niu, R., Li, R., Wang, J., Fan, X., Wang, X., & Sun, Z. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105334 · Cited by 14
Tang, W., Wang, Q., Sun, M., Liu, C., Huang, Y., Zhou, M., Zhang, X., Meng, Z., & Zhang, J. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122952 · Cited by 14
Does the gut microbiota contribute to the oligodendrocyte progenitor niche?
Sauma, S., & Casaccia, P. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134574 · Cited by 14
Torres‐Chávez, M., Torres-Carrillo, N. M., Moreal‐Lugo, A., Rancurello, S. G., Murugesan, S., Gutiérrez-Hurtado, I. A., Beltran-Ramirez, J. R., Sandoval‐Pinto, E., & Torres‐Carrillo, N. (2023) · Biomedical Reports · doi:10.3892/br.2023.1675 · Cited by 13
Xu, D., Ren, L., Zhang, W., Wu, S., Yu, M., He, X., & Wei, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33214 · Cited by 12
Neuroimmunogastroenterology: At the Interface of Neuroimmunology and Gastroenterology
Sanchez, J. M. S., McNally, J. S., Cortez, M. M., Hemp, J., Pace, L., & Clardy, S. L. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00787 · Cited by 13
Pérez-Muñoz, M. E., Sugden, S., Harmsen, H. J. M., Hart, B. A. ‘., Laman, J. D., & Walter, J. (2021) · iScience · doi:10.1016/j.isci.2021.102709 · Cited by 12
The Role of Intestinal Microbiota and Probiotics Supplementation in Multiple Sclerosis Management
Hasaniani, N., Rahimi, S. M., Akbari, M., Sadati, F., Pournajaf, A., & Rostami-Mansoor, S. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.05.013 · Cited by 12
Pyroptosis the Emerging Link Between Gut Microbiota and Multiple Sclerosis
Fan, H., Shen, R., Yan, J., Bai, Y., Fu, Q., Shi, X., Du, G., & Wang, D. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s489454 · Cited by 12
Effect of Probiotic Consumption on Immune Response in Athletes: A Meta-analysis
Tavakoly, R., Hadi, A., Rafie, N., Talaei, B., Marx, W., & Arab, A. (2021) · International Journal of Sports Medicine · doi:10.1055/a-1463-3303 · Cited by 11
Auclair‐Ouellet, N., Kassem, O., Bronner, S., Oula, M.-L., & Binda, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1699884 · Cited by 12
Bifidobacteria: A probable missing puzzle piece in the pathogenesis of multiple sclerosis
Toghi, M., Bitarafan, S., Kasmaei, H. D., & Ghafouri‐Fard, S. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101378 · Cited by 11
Combination of Probiotics and Natural Compounds to Treat Multiple Sclerosis via Warburg Effect
Ravi, A. K., & Muthukrishnan, S. (2021) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2022.057 · Cited by 10
Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation
Jank, L., & Bhargava, P. (2023) · Neurologic Clinics · doi:10.1016/j.ncl.2023.07.005 · Cited by 8
The Role of Gut-derived Short-Chain Fatty Acids in Multiple Sclerosis
Saadh, M. J., Ahmed, H. M., Alani, Z. K., Zuhairi, R. A. H. A., Almarhoon, Z. M., Ahmad, H., Ubaid, M., & Alwan, N. H. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08783-4 · Cited by 8
Role of the gut microbiome in multiple sclerosis: From etiology to therapeutics
Shahi, S. K., Yadav, M., Ghimire, S., & Mangalam, A. K. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.06.001 · Cited by 8
El holobionte enfermo, el ejemplo de la esclerosis múltiple
Castillo-Álvarez, F., & Marzo-Sola, M. E. (2018) · Medicina Clínica · doi:10.1016/j.medcli.2018.08.019 · Cited by 7
Sanchez, J. M. S., Doty, D. J., DePaula-Silva, A. B., Brown, D. G., Bell, R. S., Klag, K. A., Truong, A., Libbey, J. E., Round, J. L., & Fujinami, R. S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01959-2 · Cited by 9
Skonieczna‐Żydecka, K., Łoniewski, I., Maciejewska, D., & Marlicz, W. M. (2017) · Aktualności Neurologiczne · doi:10.15557/an.2017.0020 · Cited by 7
Hosseini, S. A., Nematollahi, S., Husain, D., Banaei-Jahromi, N., Majdinasab, N., & Rahimlou, M. (2021) · Research Square · doi:10.21203/rs.3.rs-501036/v1 · Cited by 7
Metadata
- Authors
- Tankou, S. K., Regev, K., Healy, B. C., Cox, L. M., Tjon, E., Kivisakk, P., Vanande, I. P., Cook, S., Gandhi, R., Glanz, B., Stankiewicz, J., & Weiner, H. L.
- Affiliations
- Brigham and Women's Hospital (US)
- Ann Romney Center for Neurologic Diseases, Evergrande Center for Immunologic Diseases, Partners Multiple Sclerosis Center, Brigham and Women’s Hospital and Department of Neurology, Harvard Medical School, Boston, MA, USA
- ORCID
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2018-01
- Volume
- 24
- Issue
- 1
- Pages
- 58-63
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2784311706
- Cited by
- 156
- References
- 25
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 19 · 2023: 22 · 2022: 27 · 2021: 24 · 2020: 16 · 2019: 15 · 2018: 7
- FWCI
- 14.55
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-11-27)
- Open access
- bronze
- doi.org
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Teva Pharmaceutical Industries
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- multiple sclerosis, probiotics, gut microbiota, immunomodulation, neuroinflammation, monocytes, dendritic cells, Lactobacillus, Streptococcus, Bifidobacterium, disease-modifying therapy, autoimmunity
- MeSH terms
- Gastrointestinal Microbiome, Adult, Female, Humans, Male, Middle Aged, Monocytes, Probiotics, Multiple Sclerosis, Relapsing-Remitting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
